Resibufogenin Targets the ATP1A1 Signaling Cascade to Induce G2/M Phase Arrest and Inhibit Invasion in Glioma

por Zhang, Xun, Yao, Zhong, Xue, Zhiyi, Wang, Shuai, Liu, Xuemeng, Hu, Yaotian, Zhang, Yan, Wang, Jian, Li, Xingang, Chen, Anjing
Publicado 2022

Scoring model based on the signature of non-m6A-related neoantigen-coding lncRNAs assists in immune microenvironment analysis and TCR-neoantigen pair selection in gliomas

por Zhao, Wenbo, Wu, Yibo, Zhao, Feihu, Xue, Zhiyi, Liu, Wenyu, Cao, Zenxin, Zhao, Zhimin, Huang, Bin, Han, Mingzhi, Li, Xingang
Publicado 2022

Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention

por Wang, Xu, Han, Mingzhi, Wang, Shuai, Sun, Yanfei, Zhao, Wenbo, Xue, Zhiyi, Liang, Xiangjun, Huang, Bin, Li, Gang, Chen, Anjing, Li, Xingang, Wang, Jian
Publicado 2022

Valtrate, an iridoid compound in Valeriana, elicits anti-glioblastoma activity through inhibition of the PDGFRA/MEK/ERK signaling pathway

por Liu, Xuemeng, Hu, Yaotian, Xue, Zhiyi, Zhang, Xun, Liu, Xiaofei, Liu, Guowei, Wen, Muzi, Chen, Anjing, Huang, Bin, Li, Xingang, Yang, Ning, Wang, Jian
Publicado 2023

TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein

por Yang, Xu, Zhang, Yan, Xue, Zhiwei, Hu, Yaotian, Zhou, Wenjing, Xue, Zhiyi, Liu, Xuemeng, Liu, Guowei, Li, Wenjie, Liu, Xiaofei, Li, Xingang, Han, Mingzhi, Wang, Jian
Publicado 2022

A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China

por Tu, Hai-Yan, Feng, Jifeng, Shi, Meiqi, Zhao, Jun, Wang, Yuyan, Chang, Jianhua, Wang, Jialei, Cheng, Ying, Zhu, Jing, Tan, Eng-Huat, Li, Kai, Zhang, Yiping, Lee, Victor, Yang, Cheng-Ta, Su, Wu-Chou, Lam, David Chi-Leung, Srinivasa, B. J., Rajappa, Senthil, Ho, Ching-Liang, Lam, Kwok Chi, Hu, Yi, Bondarde, Shailesh Arjun, Liu, Xiaoqing, Tian, Yahui, Xue, Zhiyi, Cseh, Agnieszka, Huang, Dennis Chin-Lun, Zhou, Caicun, Wu, Yi-Long
Publicado 2022